PCIA
AMGN icon

Prime Capital Investment Advisors’s Amgen AMGN Stock Holding History

Prime Capital Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$211 – 969
2025
Q1 		$211 Buy
+100
New +$29.5K ﹤0.01% 1068

Other funds holding AMGN

Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Prime Capital Investment Advisors's AMGN Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its Amgen (AMGN) stake by 9.6% in Q2 2026, selling an estimated $573K and leaving 15,849 shares worth $5.74M. The position accounts for 0.06% of the portfolio, ranked #216.

Prime Capital Investment Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $15.6M in Q3 2024. 1,860 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Prime Capital Investment Advisors held 15,849 shares of Amgen worth $5.74M as of Q2 2026.
  • Prime Capital Investment Advisors sold 1,674 Amgen shares in Q2 2026, an estimated $573K.
  • Amgen made up 0.06% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #216 holding.
  • Prime Capital Investment Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
  • Prime Capital Investment Advisors's Amgen position peaked at $15.6M in Q3 2024.
  • 1,860 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.